| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/10/2000 | CN1252277A Quick soluble breviscapine B tablet and its preparation |
| 05/10/2000 | CN1252276A Medicament containing 1-(2'-gamma-pyrone)-6-caffacyl-B-D-pyranoglucoside and its preparation |
| 05/10/2000 | CN1252275A Breast pumping up massage oil |
| 05/10/2000 | CN1252273A Preparation and application of seleno-methionine chrome yellow urea as hypoglycemic |
| 05/10/2000 | CN1252269A Slimming liquid smeared to body |
| 05/10/2000 | CN1252238A Stable powder tomato red agent preparation containing crystallinity large than 20% tomato red agent |
| 05/10/2000 | CN1052240C Method for preparing inhibitor of retroinfection viral protease |
| 05/10/2000 | CN1052238C Conception promoting 19,11 overbridge estratrene |
| 05/10/2000 | CN1052237C Steroids with 17-spiromethylene lactone or ortho -hydroxyl inner ether base |
| 05/10/2000 | CN1052236C Process for prepn. of ivermectin |
| 05/10/2000 | CN1052233C Alkaloids from mappia foetida, the use and formulations containing them |
| 05/10/2000 | CN1052232C Substituted oxazine derivatives |
| 05/10/2000 | CN1052231C 2-oxo-5-oxazolidone methyl compound their preparing method and medicinal composition containing them |
| 05/10/2000 | CN1052229C 7-deoxy taxols and its medicinal composition |
| 05/10/2000 | CN1052227C Oxazolidone used as adhesive receptor antagenists, its preparing method and medicinal composition containing them |
| 05/10/2000 | CN1052225C Huperzia alkali A derivative, its preparing method and use |
| 05/10/2000 | CN1052218C Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromans |
| 05/10/2000 | CN1052164C Chinese medicinal preparation for senile dementia |
| 05/10/2000 | CN1052156C Medicine for curing acne |
| 05/10/2000 | CN1052155C Process for preparing pharmaceutical composition containing new steriod compounds |
| 05/10/2000 | CA2287775A1 Attenuated forms of bovine viral diarrhea virus |
| 05/09/2000 | US6060616 Antitumors agents; leukemia, ovarian carcinoma |
| 05/09/2000 | US6060604 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
| 05/09/2000 | US6060600 Substituted tetronic acids useful for treating HIV and other retroviruses |
| 05/09/2000 | US6060597 Cyclic oligosaccharide, and an agent containing the same for preventing or treating retroviral diseases |
| 05/09/2000 | US6060595 Inhibition of viral replication |
| 05/09/2000 | US6060592 Pyrimidine nucleoside compounds and oligonucleoside compounds containing same |
| 05/09/2000 | US6060518 Polymer compositions for chemotherapy and methods of treatment using the same |
| 05/09/2000 | US6060517 Process for removing bile salts from a patient and compositions therefor |
| 05/09/2000 | US6060515 Topically applying to mammalian skin or mucous membrane a barrier development enhancing amount of peroxisome proliferator-activated receptor alpha (ppara) |
| 05/09/2000 | US6060512 Method of using hydroxycarboxylic acids or related compounds for treating skin changes asociated with intrinsic and extrinsic aging |
| 05/09/2000 | US6060511 Trans-sodium crocetinate, methods of making and methods of use thereof |
| 05/09/2000 | US6060510 Administering dosage of nontoxic title ester compound to treat beta-hemoglobinopathies |
| 05/09/2000 | US6060509 Administering dosage of terpenoid plant extract to treat fungal infection in mammal |
| 05/09/2000 | US6060508 Benzylamine derivatives, their preparation and their application in therapeutics |
| 05/09/2000 | US6060506 Benzopyran derivatives as melatonergic agents |
| 05/09/2000 | US6060505 Method of treating cancer using C-26 modified bryostatin |
| 05/09/2000 | US6060504 Administering heat stable crystal form of kappa-opiate agonist asimadoline hydrochloride to treat inflammatory gastrointestinal disorders and simultaneously relieve pain with side effect reduction |
| 05/09/2000 | US6060503 Antiestrogenic, anticarcinogenic stereospecific benzopyran derivative; breast cancer |
| 05/09/2000 | US6060500 Suppression, by 5-lipoxygenase inhibitors, of bone resorption |
| 05/09/2000 | US6060499 Concurrently administering mixture of long-acting non-steroidal antiinflammatory drug (la-nsaid) with 5ht agonist to reduce relapse |
| 05/09/2000 | US6060498 N-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide dissolved together with a base to form alkaline aqueous solution for parenteral injection |
| 05/09/2000 | US6060496 Long lasting at small dosages |
| 05/09/2000 | US6060494 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 05/09/2000 | US6060492 Side effect reduction |
| 05/09/2000 | US6060487 Indanol compounds |
| 05/09/2000 | US6060486 Carbostyril derivative for curing ophthalmological diseases |
| 05/09/2000 | US6060484 Anti-viral method |
| 05/09/2000 | US6060483 Ergoline derivatives |
| 05/09/2000 | US6060482 Serotonin inhibitors |
| 05/09/2000 | US6060481 Method for improving insulin sensitivity using an adenosine receptor antagonist |
| 05/09/2000 | US6060480 Preventives/remedies for muscle tissue degenerations |
| 05/09/2000 | US6060479 Quinazoline-4-one AMPA antagonists |
| 05/09/2000 | US6060477 Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives |
| 05/09/2000 | US6060476 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 05/09/2000 | US6060475 Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof |
| 05/09/2000 | US6060474 Method for preventing scar tissue formation |
| 05/09/2000 | US6060473 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands |
| 05/09/2000 | US6060469 Spiro-piperidine derivatives and their use as tachykinin antagonists |
| 05/09/2000 | US6060468 N-substituted azaheterocyclic compounds |
| 05/09/2000 | US6060467 Graft survival prolongation with porphyrins |
| 05/09/2000 | US6060465 Bile acids and their derivatives as glycoregulatory agents |
| 05/09/2000 | US6060464 Compounds and pharmaceutical compositions containing them |
| 05/09/2000 | US6060463 Treatment of conditions of abnormally increased intraocular pressure by administration of phosphonylmethoxyalkyl nucleoside analogs and related nucleoside analogs |
| 05/09/2000 | US6060461 Topically applied clotting material |
| 05/09/2000 | US6060460 Use of betaglycan to reduce scarring |
| 05/09/2000 | US6060459 Enhancing blood cell count with oxypurine nucleosides |
| 05/09/2000 | US6060458 Oligodeoxyribonucleotides comprising O6 -benzylguanine and their use |
| 05/09/2000 | US6060454 Administering beta-blocker and atrioventricular node blocker to induce reversible ventricular asystole |
| 05/09/2000 | US6060453 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
| 05/09/2000 | US6060450 Administering tau-interferon to treat multiple sclerosis, rheumatoid arthritis, diabetes, and lupus |
| 05/09/2000 | US6060446 Protein and carnosine, glutathione, and/or cyclo-histidine-proline |
| 05/09/2000 | US6060311 Identifying a compound that inhibits retinoic acid suppression of ventricular muscle cell hypertrophy |
| 05/09/2000 | US6060308 RNA respiratory syncytial virus vaccines |
| 05/09/2000 | US6060304 Lactobacillus strain |
| 05/09/2000 | US6060303 Use in screening assays and as pharmaceuticals. |
| 05/09/2000 | US6060300 Thrombin muteins as antidotes for thrombin inhibitors |
| 05/09/2000 | US6060270 Central lumen bordered by polarized epithelium and produced by culturing in all-trans retinoic acid, transforming growth factor-beta-1 and either epidermal growth factor or transforming growth factor-alpha; for kidney disorders |
| 05/09/2000 | US6060235 Treating a viral infection by administering nonhydrolyzable polymer to a mammal; inhibits viral attachment to mammalian cells |
| 05/09/2000 | US6060083 Topical DMSO treatment for palmar-plantar erythrodysethesia |
| 05/09/2000 | US6060077 Unit galenical formulation for local hormonotherapy of vaginal dryness |
| 05/09/2000 | US6060073 Polyvinyl chloride having a tensile strength of between approximately 3500 psi and 10,000 psi and which is between approximately 6 and 50 mils thick. |
| 05/09/2000 | US6060071 Ectoin and ectoin derivatives as moisturizers in cosmetics |
| 05/09/2000 | US6060070 Isoflavonoids for treatment and prevention of aging skin and wrinkles |
| 05/09/2000 | US6060062 Liquid composition for the topical application to relieve arthritic pain |
| 05/09/2000 | US6060052 Expanding primitive stem cells for restoration of hematopoietic capabilities and for providing modified human stem cells for gene therapy applications; transplantation of human hematopoietic stem cells |
| 05/09/2000 | US6060042 Use of cholesteric, liquid-crystalline compositions as UV filters in cosmetic and pharmaceutical preparations |
| 05/09/2000 | US6060038 Radiolabeled farnesyl-protein transferase inhibitors |
| 05/09/2000 | US6060037 Conjugated compounds which comprise an st receptor binding moiety and a radiostable active moiety |
| 05/09/2000 | CA2202348C Indole derivatives as 5ht1-like agonists |
| 05/09/2000 | CA2181168C Antiparasitic pyrrolobenzoxazine compounds |
| 05/09/2000 | CA2159786C Dibenzofuran derivatives compounds; pharmaceutical and cosmetic compositions containing the same |
| 05/09/2000 | CA2151560C Insulin analog formulations |
| 05/09/2000 | CA2129679C Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring |
| 05/09/2000 | CA2112239C Enantiomeric hydroxylated xanthine compounds |
| 05/09/2000 | CA2084412C Pyrrolidine and thiazolidine amides |
| 05/09/2000 | CA2065285C Antimalarial compositions |
| 05/09/2000 | CA2058940C Targeted liposomes and methods for liposome-protein coupling |
| 05/09/2000 | CA2030838C Preparations containing l-carnitine |
| 05/09/2000 | CA2019944C Process for reducing the crystal size of ondansetron hydrochloride dihydrate |